|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 | |
| C07D 401/14 | |||
| C07D 413/14 | |||
| A61K 31/41 | |||
| A61K 31/445 | |||
| A61K 31/66 | |||
| A61P 37/00 |
| (11) | Number of the document | 1758578 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05769167.7 |
| Date of filing the European patent application | 2005-06-24 | |
| (97) | Date of publication of the European application | 2007-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2010-12-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/022870 |
| Date | 2005-06-24 |
| (87) | Number | WO 2006/002434 |
| Date | 2006-01-05 |
| (30) | Number | Date | Country code |
| 582655 P | 2004-06-24 | US |
| (72) |
KERNS, Jeffrey, K., US
EDWARDS, Christine, Argenta Discovery Limited, GB
|
| (73) |
GlaxoSmithKline LLC,
One Franklin Plaza 200 North 16th Street, Philadelphia, PA 19102,
US
|
| (54) | NOVEL INDAZOLE CARBOXAMIDES AND THEIR USE |
| NOVEL INDAZOLE CARBOXAMIDES AND THEIR USE |